These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 17165604

  • 1. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
    Temesvári A, Bálint OH, Liptai C, Kancz S, Németh B, Szatmári A.
    Orv Hetil; 2006 Oct 22; 147(42):2035-9. PubMed ID: 17165604
    [Abstract] [Full Text] [Related]

  • 2. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V, Reisman M, Fuller CJ, Spencer MP, Olsen JV, Krabill KA, Gray WA, Jesurum JT.
    Am J Cardiol; 2007 May 01; 99(9):1312-5. PubMed ID: 17478164
    [Abstract] [Full Text] [Related]

  • 3. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
    Silverman IE, Kiernan FJ, Kelsey AM, Brakoniecki JJ, Kazi FA, Dougherty JE, Boden WE, McKay RG.
    Conn Med; 2003 Mar 01; 67(3):135-44. PubMed ID: 12687787
    [Abstract] [Full Text] [Related]

  • 4. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N.
    Catheter Cardiovasc Interv; 2006 Nov 01; 68(5):741-6. PubMed ID: 17039525
    [Abstract] [Full Text] [Related]

  • 5. Clinical and brain magnetic resonance imaging follow-up after percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
    Vigna C, Inchingolo V, Giannatempo G, Pacilli MA, Di Viesti P, Fusilli S, Amico CM, Santoro T, Lanna P, Fanelli R, Simone P, Loperfido F.
    Am J Cardiol; 2008 Apr 01; 101(7):1051-5. PubMed ID: 18359330
    [Abstract] [Full Text] [Related]

  • 6. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M.
    Catheter Cardiovasc Interv; 2007 Sep 01; 70(3):429-33. PubMed ID: 17722021
    [Abstract] [Full Text] [Related]

  • 7. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 01; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 8. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale.
    Giardini A, Donti A, Formigari R, Salomone L, Palareti G, Guidetti D, Picchio FM.
    Int J Cardiol; 2007 Sep 03; 120(3):357-62. PubMed ID: 17166607
    [Abstract] [Full Text] [Related]

  • 9. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 10. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM, Amplatzer PFO Investigators.
    Catheter Cardiovasc Interv; 2003 Dec 15; 60(4):524-8. PubMed ID: 14624434
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP, Cammalleri V, Mulè M, Scarabelli M, Barbanti M, Scardaci F, Mangiafico S, Immè S, Capodanno D, Tamburino C.
    Catheter Cardiovasc Interv; 2009 Oct 01; 74(4):607-14. PubMed ID: 19360875
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, Del Sette M, Barsotti A.
    Am Heart J; 2008 Aug 01; 156(2):356-60. PubMed ID: 18657668
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE, Kipshidze N, Chiam PT, Gogorishvili I.
    Catheter Cardiovasc Interv; 2008 Jun 01; 71(7):921-6. PubMed ID: 18412251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Percutaneous device closure of the patent foramen ovale during pregnancy.
    Schrale RG, Ormerod J, Ormerod OJ.
    Catheter Cardiovasc Interv; 2007 Mar 01; 69(4):579-83. PubMed ID: 17295329
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.